Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115296298 | 11529629 | 8 | F | 20150915 | 20160721 | 20150921 | 20160727 | EXP | CA-ROCHE-1636706 | ROCHE | 55.48 | YR | F | Y | 0.00000 | 20160727 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115296298 | 11529629 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0060,S0061D,S0062,S0066B,S0002F | 103976 | 300 | MG | SOLUTION FOR INJECTION | ||||||
115296298 | 11529629 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0060,S0061D,S0062,S0066B,S0002F | 103976 | SOLUTION FOR INJECTION | ||||||||
115296298 | 11529629 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0060,S0061D,S0062,S0066B,S0002F | 103976 | SOLUTION FOR INJECTION | ||||||||
115296298 | 11529629 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0060,S0061D,S0062,S0066B,S0002F | 103976 | SOLUTION FOR INJECTION | ||||||||
115296298 | 11529629 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0060,S0061D,S0062,S0066B,S0002F | 103976 | SOLUTION FOR INJECTION | ||||||||
115296298 | 11529629 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0060,S0061D,S0062,S0066B,S0002F | 103976 | SOLUTION FOR INJECTION | ||||||||
115296298 | 11529629 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0060,S0061D,S0062,S0066B,S0002F | 103976 | SOLUTION FOR INJECTION | ||||||||
115296298 | 11529629 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0060,S0061D,S0062,S0066B,S0002F | 103976 | SOLUTION FOR INJECTION | ||||||||
115296298 | 11529629 | 9 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0060,S0061D,S0062,S0066B,S0002F | 103976 | SOLUTION FOR INJECTION | ||||||||
115296298 | 11529629 | 10 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | U | 0 | ||||||||||
115296298 | 11529629 | 11 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | U | 0 | ||||||||||
115296298 | 11529629 | 12 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Unknown | U | 0 | ||||||||||
115296298 | 11529629 | 13 | C | PREDNISONE. | PREDNISONE | 1 | Oral | U | 0 | 40 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
115296298 | 11529629 | 1 | Asthma |
115296298 | 11529629 | 10 | Product used for unknown indication |
115296298 | 11529629 | 11 | Product used for unknown indication |
115296298 | 11529629 | 12 | Product used for unknown indication |
115296298 | 11529629 | 13 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
115296298 | 11529629 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
115296298 | 11529629 | Blood pressure increased | |
115296298 | 11529629 | Body temperature increased | |
115296298 | 11529629 | Heart rate increased | |
115296298 | 11529629 | Hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
115296298 | 11529629 | 1 | 20150915 | 0 | ||
115296298 | 11529629 | 2 | 20160107 | 0 | ||
115296298 | 11529629 | 3 | 20160204 | 0 | ||
115296298 | 11529629 | 4 | 20160303 | 0 | ||
115296298 | 11529629 | 5 | 20160331 | 0 | ||
115296298 | 11529629 | 6 | 20160427 | 0 | ||
115296298 | 11529629 | 7 | 20160526 | 0 | ||
115296298 | 11529629 | 8 | 20160623 | 0 | ||
115296298 | 11529629 | 9 | 20160721 | 0 |